AKBA insider buying and SEC filings, explained
Akebia Therapeutics, Inc. · CIK 1517022
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$87K
Insiders who bought
1
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$963K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jun 29, 2026 | Planned (10b5-1) | Erik Ostrowski (CFO) sold 56,019 shares at $1.11 ($62K), marked as a 10b5-1 plan trade. Holdings down 8% to 616,616 shares. | SEC filing Filed Jul 1, 2026 |
| Mar 4, 2026 | Purchase (code P) | John P. Butler (CEO and Director) bought 69,270 shares at about $1.25 ($87K), reported as a purchase (code P). Holdings up 2% to 3,367,064 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 5, 2026 |
| Feb 2, 2026 | Planned (10b5-1) | Carolyn M. Rucci (SVP, Chief Legal Officer) sold 69,772 shares at $1.39 ($97K), marked as a 10b5-1 plan trade. Holdings down 11% to 588,378 shares. | SEC filing Filed Feb 4, 2026 |
| Feb 2, 2026 | Planned (10b5-1) | Richard C Malabre (SVP, Chief Accounting Officer) sold 49,524 shares at $1.39 ($69K), marked as a 10b5-1 plan trade. Holdings down 14% to 299,390 shares. | SEC filing Filed Feb 4, 2026 |
| Feb 2, 2026 | Planned (10b5-1) | Erik Ostrowski (CFO) sold 34,951 shares at $1.39 ($49K), marked as a 10b5-1 plan trade. Holdings down 5% to 672,635 shares. | SEC filing Filed Feb 4, 2026 |
| Feb 2, 2026 | Planned (10b5-1) | Nicholas Grund (Chief Commercial Officer) sold 84,829 shares at $1.39 ($118K), marked as a 10b5-1 plan trade. Holdings down 13% to 561,750 shares. | SEC filing Filed Feb 4, 2026 |
| Feb 2, 2026 | Planned (10b5-1) | Steven Keith Burke (SVP, Chief Medical Officer) sold 67,658 shares at $1.39 ($94K), marked as a 10b5-1 plan trade. Holdings down 7% to 948,432 shares. | SEC filing Filed Feb 4, 2026 |
| Feb 2, 2026 | Planned (10b5-1) | John P. Butler (CEO and Director) sold 341,305 shares at $1.39 ($474K), marked as a 10b5-1 plan trade. Holdings down 9% to 3,297,794 shares. | SEC filing Filed Feb 4, 2026 |
15 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow AKBA in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.